MinichMacGregor Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

MinichMacGregor Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,083	Closed	-$320K	–	167
2026 Q1	$320K	Buy	+3,083	New	+$326K	0.06%	94
2023 Q1	–	Sell	-36	Closed	-$2.83K	–	487
2022 Q4	$2.83K	Buy	+36	New	+$2.77K	﹤0.01%	543
2018 Q4	–	Sell	-36	Closed	-$2K	–	383
2018 Q3	$2K	Hold	36	–	–	﹤0.01%	458
2018 Q2	$2K	Buy	+36	New	+$2.32K	﹤0.01%	449

Other funds holding PJP

Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SAM

Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Cordant Inc Portland, Oregon $278M AUM 23.17% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

CBT

Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return

MinichMacGregor Wealth Management's PJP Position: Q2 2026 in Review

MinichMacGregor Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 3,083 shares — an estimated $320K sold.

MinichMacGregor Wealth Management first reported a position in PJP in Q2 2018 and held it in 4 quarters. The position peaked at $320K in Q1 2026. 16 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

MinichMacGregor Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
MinichMacGregor Wealth Management sold 3,083 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $320K.
MinichMacGregor Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2018 and held it in 4 quarters.
MinichMacGregor Wealth Management's Invesco Pharmaceuticals ETF position peaked at $320K in Q1 2026.
16 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on MinichMacGregor Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.